Evidence map›Paper›PMID 33466665›Full record

ArticleCancers2021

Dysbiosis Triggers ACF Development in Genetically Predisposed Subjects.

Stefania De Santis, Marina Liso, Mirco Vacca, Giulio Verna, Elisabetta Cavalcanti, Sergio Coletta, Francesco Maria Calabrese, Rajaraman Eri, Antonio Lippolis, Raffaele Armentano and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Enhanced CRC Growth in Iron-Rich Environment, Facts and Speculations.International journal of molecular sciences · 2024
    Review
  4. Article
  5. Deletion of TNF in Winnie-International journal of molecular sciences · 2022
    Article
  6. Article
  7. Observational
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Stefania De SantisDepartment of Pharmacy-Drug Science, University of Bari Aldo Moro, 70126 Bari, Italy.ORCID 0000-0001-6877-2208
Marina LisoResearch Department, National Institute of Gastroenterology "S. de Bellis", Research Hospital, 70013 Castellana Grotte, Italy.ORCID 0000-0002-8766-1869
Mirco VaccaDepartment of Soil, Plant and Food Sciences, University of Bari, 70126 Bari, Italy.ORCID 0000-0003-0813-169X
Giulio VernaDepartment of Pharmacy, University of Salerno, 84084 Fisciano, Italy.ORCID 0000-0001-8329-0370
Elisabetta CavalcantiResearch Department, National Institute of Gastroenterology "S. de Bellis", Research Hospital, 70013 Castellana Grotte, Italy.ORCID 0000-0003-2952-0053
Sergio ColettaResearch Department, National Institute of Gastroenterology "S. de Bellis", Research Hospital, 70013 Castellana Grotte, Italy.ORCID 0000-0003-3359-7010
Francesco Maria CalabreseDepartment of Soil, Plant and Food Sciences, University of Bari, 70126 Bari, Italy.ORCID 0000-0003-0176-7046
Rajaraman EriSchool of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS 7250, Australia.ORCID 0000-0003-1688-8043
Antonio LippolisResearch Department, National Institute of Gastroenterology "S. de Bellis", Research Hospital, 70013 Castellana Grotte, Italy.
Raffaele ArmentanoResearch Department, National Institute of Gastroenterology "S. de Bellis", Research Hospital, 70013 Castellana Grotte, Italy.
Mauro MastronardiResearch Department, National Institute of Gastroenterology "S. de Bellis", Research Hospital, 70013 Castellana Grotte, Italy.
Maria De AngelisDepartment of Soil, Plant and Food Sciences, University of Bari, 70126 Bari, Italy.ORCID 0000-0002-2010-884X
Marcello ChieppaResearch Department, National Institute of Gastroenterology "S. de Bellis", Research Hospital, 70013 Castellana Grotte, Italy.ORCID 0000-0001-9819-0823
Gastroenterology Hospital "Saverio de Bellis" · ITUniversity of Bari Aldo Moro · ITUniversity of Salerno · ITUniversity of Tasmania · AU

Funding

M.I.Cro. 5x1000Ministero della Salute Ricerca Corrente 2019Regione Puglia PON "2014-2020 E FSC - C.P. ARS01_01220" - BIOMISRegione Puglia PON - Ricerca e Innovazione 2014-2020 - Progetto AIM1801289 - attività 3 - linea 1
6 · The paper itself

Abstract

backgroundColorectal cancer (CRC) is the third most common cancer worldwide, characterized by a multifactorial etiology including genetics, lifestyle, and environmental factors including microbiota composition. To address the role of microbial modulation in CRC, we used our recently established mouse model (the Winnie-APC

methodsGut microbiota profiling was performed on 8-week-old Winnie-APC

resultsACF development in 8-week-old Winnie-APC

conclusionsThe characterization of microbiota profiling supporting CRC development in genetically predisposed mice could help to design therapeutic strategies to prevent dysbiosis. The application of these strategies in mothers during pregnancy and lactation could also reduce the CRC risk in the offspring.

Indexed as

colorectal cancerdysbiosismicrobiotamurine modelulcerative colitis

Identifiers

PMID33466665
PMCPMC7828790
OpenAlexW3119761389

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.